Press release content from Business Wire. The AP news staff was not involved in its creation.
Ecommerce’s Rising Tide? More Like a Tsunami: Signifyd’s Top 500 Customers More Than Doubled Their Revenue in 2020
January 28, 2021 GMT
SAN JOSE, Calif. (BUSINESS WIRE) Jan 28, 2021
As a measure of the depth and breadth of the consumer shift to digital commerce, each of Signifyd’s top 500 customers more than doubled their ecommerce revenue in 2020. The combination of their own agility and Signifyd’s AI-driven innovation allowed them to power through pandemic disruptions and fulfill consumer orders at record-breaking volume and speed.
ADVERTISEMENT
Press release content from Wired Release. The AP news staff was not involved in its creation.
Floor-Standing Lamp Market Report to Cover Manufacturing Cost Structure and Process Analysis- BOVER Barcelona, BRASS BROTHERS and BROKIS
January 28, 2021 GMT
Pune, Maharashtra, India, January 28 2021 (Wiredrelease) Prudour Pvt. Ltd :New Report On the Floor-Standing Lamp Market: Professional and In-depth Study Descriptions
Worldwide Floor-Standing Lamp Market (up-to-date) impart a basic compendium of the trade along with type and end-user, analyzes the rate and scope of expansion of the market on a global front. This market expected to witness substantial growth from 2022 to 2031 (forecast period). This research data presents a scrupulous review and technical research, with useful statistics and facts with figures, of the current and future state of the Floor-Standing Lamp market over the globe and also opportunities, changing consumer demand and steady growth trail that will fuel these g
Press release content from Business Wire. The AP news staff was not involved in its creation.
BeiGene Announces Positive Topline Results for Global Phase 3 Trial of Tislelizumab in Esophageal Squamous Cell Carcinoma
January 27, 2021 GMT
CAMBRIDGE, Mass. & BEIJING (BUSINESS WIRE) Jan 27, 2021
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the global Phase 3 RATIONALE 302 trial of its anti-PD-1 antibody tislelizumab versus investigator’s choice chemotherapy in patients with advanced unresectable or metastatic esophageal squamous cell carcinoma (ESCC) who have received prior systemic treatment met its primary endpoint of overall survival (OS). In the trial results, tislelizumab demonstrated a statistically significant and clinically meaningful improvement in OS in the intention-to-treat (ITT) population, when compared to chemotherapy. The safety prof
Press release content from Accesswire. The AP news staff was not involved in its creation.
CO2 GRO Inc. Announces a Commercial Feasibility with Plant Advanced Technologies PAT in France in Conjunction with Marketing Partner Rika Biotech
January 27, 2021 GMT
TORONTO, ON and NANCY, FRANCE / ACCESSWIRE / January 27, 2021 / Toronto based CO2 GRO Inc. (“GROW”) (TSXV:GROW)(OTCQB:BLONF)(Frankfurt:4021) is pleased to announce its first commercial feasibility in the EU with France based Plant Advanced Technologies PAT (“PAT”) (EURONEXT GROWTH Paris ISIN: FR0010785790 ALPAT). It is also the first partnership with its UK based Marketing Partner Rika Biotech (“Rika”) that is exclusively representing CO2 Delivery Solutions™ in the UK, the Netherlands and Belgium greenhouse markets. The commercial feasibility is on medicinal plants and is the first on such plants other than Cannabis and hemp. PAT contacted GROW directly concerning CO2 Delivery Solutions™. While Rika is exclusiv